Teens Love Snapchat But What About Adults?
It no surprise that Snapchat—the photo/video sharing mobile app—is marketing gold for teenagers but as the company is set to debut on Wall Street’s biggest stage on Thursday—the big question for investors is can they gain ground with the 30 + crowd.
Why the number of IPOs is falling, according to Nasdaq's CEO
Nasdaq CEO Adena Friedman discusses the status of the IPO market in 2018.
Nasdaq CEO says regulations are partially to blame for IPO decline
Nasdaq CEO on IPOs
Silicon Valley tech companies are gearing up to go public
Tech companies to go public
Time to invest in tech?
Tech IPOs to watch
Uber IPO could be worth up to $120B
The ride-hailing IPO may come sooner than expected.
Carl Icahn boosts stake in Dell IPO standoff
Dell said earlier this month that it had met with some investment banks to explore an initial public offering if its plan to buy the tracking stock of VMware falls through.
IPO market is on a trend upwards, NYSE president says
Market selloff and IPOs
IPO market showing 'positive signs,' NYSE president says
The number of IPOs in 2018 has outpaced those in 2016 and 2017.
Tencent Music pauses IPO amid market turmoil
The Chinese music-streaming company is postponing its U.S. IPO until at least November, report says.
Aston Martin prices IPO at $5.6 billion, sputters in debut
Shares of the British sports car maker fell in their first day of trading.
China's music streaming leader Tencent to go public in US
The owner of China's largest music streaming services is looking to strike it rich in the U.S. stock market.
Slack, workplace-messaging app firm, going public
The IPO could value company’s worth over $7 billion.
Sheryl Sandberg will donate SurveyMonkey IPO proceeds to honor late husband
The Facebook COO will honor her late husband with a poignant donation.
Eli Lilly spin-off Elanco creating ‘disruptive’ opportunity in animal health: CEO
Elanco CEO on Eli Lilly spinoff
Aston Martin targets $6.7 billion IPO valuation
The British sports car maker plans to go public in October.
Elon Musk’s missteps have Chobani’s CEO thinking twice about going public
The yogurt chief gets candid on the company’s future.
Biopharmaceutical company fined for misleading investors
A Colorado-based biopharmaceutical company has been penalized more than $20 million for misleading investors about the efficacy of a lung cancer drug under development before raising $300 million in a public stock offering.
DraftKings CEO on Buffalo Wild Wings partnership
DraftKings CEO on sports betting

















